$7.08
0.588.85%
At Close: -
$6.99
-0.08-1.20%
After Hours: Jul 16, 7:52 PM EDT
15 minutes delayed
Comments
Loading...
Burning Rock Biotech
BNRNASDAQ
Burning Rock Biotech (NASDAQ:BNR) Stock, Earnings Estimates, EPS, And Revenue
Burning Rock Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 29
EPS
$-1.600
Quarterly Revenue
$17.4M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$520.5M
Analyze the earnings history of Burning Rock Biotech using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BNR | Burning Rock Biotech | -$1.80 | — | — | — | $20.17M | — | — | — | 08/29/2024 | Get Alert |
| BNR | Burning Rock Biotech | -$2.60 | — | -$1.60 | — | $20.75M | — | $17.40M | — | 05/29/2024 | Get Alert |
| BNR | Burning Rock Biotech | -$3.10 | — | -$2.20 | — | $20.62M | — | $17.05M | — | 03/28/2024 | Get Alert |
| BNR | Burning Rock Biotech | -$3.10 | — | -$2.30 | — | $21.74M | — | $17.48M | — | 11/30/2023 | Get Alert |
| BNR | Burning Rock Biotech | -$3.70 | — | -$1.80 | — | $19.53M | — | $20.17M | — | 08/31/2023 | Get Alert |
| BNR | Burning Rock Biotech | -$3.90 | — | -$2.60 | — | $21.38M | — | $20.75M | — | 05/30/2023 | Get Alert |
| BNR | Burning Rock Biotech | -$3.80 | -$3.80 | -$3.10 | 18.42% | $23.12M | $16.10M | $20.62M | 28.09% | 03/28/2023 | Get Alert |
| BNR | Burning Rock Biotech | -$2.50 | -$3.20 | -$3.10 | 3.12% | $19.65M | $21.15M | $21.74M | 2.78% | 11/15/2022 | Get Alert |
| BNR | Burning Rock Biotech | -$3.00 | -$3.50 | -$3.70 | -5.71% | $19.71M | $22.15M | $19.53M | -11.81% | 08/31/2022 | Get Alert |
| BNR | Burning Rock Biotech | -$2.50 | -$3.60 | -$3.90 | -8.33% | $16.27M | $20.81M | $21.38M | 2.73% | 05/31/2022 | Get Alert |
| BNR | Burning Rock Biotech | -$2.30 | -$2.70 | -$3.80 | -40.74% | $20.19M | $21.47M | $23.12M | 7.69% | 03/21/2022 | Get Alert |
| BNR | Burning Rock Biotech | -$1.80 | -$2.50 | -$2.50 | 0.00% | $18.25M | $20.15M | $19.65M | -2.48% | 11/16/2021 | Get Alert |
| BNR | Burning Rock Biotech | -$3.80 | -$1.50 | -$3.00 | -100.00% | $15.14M | $21.41M | $19.71M | -7.93% | 08/31/2021 | Get Alert |
| BNR | Burning Rock Biotech | — | -$2.30 | -$2.50 | -8.70% | — | $19.56M | $16.27M | -16.80% | 05/25/2021 | Get Alert |
| BNR | Burning Rock Biotech | — | -$2.00 | -$2.30 | -15.00% | — | $20.47M | $20.19M | -1.38% | 03/11/2021 | Get Alert |
| BNR | Burning Rock Biotech | — | -$1.20 | -$1.80 | -50.00% | — | $18.09M | $18.25M | 0.86% | 11/20/2020 | Get Alert |
| BNR | Burning Rock Biotech | — | -$2.00 | -$3.80 | -90.00% | — | $13.50M | $15.14M | 12.16% | 08/11/2020 | Get Alert |
Burning Rock Biotech (BNR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2022 | 2023-03-28 | $-3.10 | $-3.80 | 18.4 % |
| Sep 2022 | 2022-11-15 | $-3.10 | $-3.20 | 3.12 % |
| Jun 2022 | 2022-08-31 | $-3.70 | $-3.50 | -5.71 % |
| Mar 2022 | 2022-05-31 | $-3.90 | $-3.60 | -8.33 % |
Burning Rock Biotech (BNR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2022 | 2023-03-28 | $20.62M | $16.10M | 28.1 % |
| Sep 2022 | 2022-11-15 | $21.74M | $21.15M | 2.78 % |
| Jun 2022 | 2022-08-31 | $19.53M | $22.15M | -11.8 % |
| Mar 2022 | 2022-05-31 | $21.38M | $20.81M | 2.73 % |
FAQ
When is Burning Rock Biotech (NASDAQ:BNR) reporting earnings?
Burning Rock Biotech (BNR) is scheduled to report earnings on August 29, 2024. The last reported earnings were for reported on May 29, 2024 for Q1.
What were the latest earnings per share (EPS) for Burning Rock Biotech (NASDAQ:BNR)?
The Actual EPS was $-1.60, which missed the estimate of $0.00.
What were Burning Rock Biotech’s (NASDAQ:BNR) revenues?
The Actual Revenue was $17.4M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.